Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,408.50
(
-1.24%
)
US TECH 100
28,244.40
(
-1.90%
)
Dow Jones
49,526.17
(
-1.07%
)
Brent Oil
106.70
(
0.00%
)
Bitcoin
78,148.42
(
0.00%
)
News Focus
News Focus
Post# of 55
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

whytestocks

Send PM Follow Ignore
Followers 131
Posts 15004
Boards Moderated 0
Alias Born 06/04/2018

whytestocks

Re: None

Monday, 01/21/2019 7:36:14 AM

Monday, January 21, 2019 7:36:14 AM

Post# of 55
News: $BTI Nash Pharmaceuticals Announces 84% Reduction of Fibrosis by Additional Lead Compound In Second Pre-Clinical Study For Non-Alcoholic Fatty Liver Disease

VANCOUVER, British Columbia, Jan. 21, 2019 (GLOBE NEWSWIRE) -- Nash Pharmaceuticals Inc., a wholly owned subsidiary of Breathtec Biomedical Inc. (CSE:  BTH ) (CNSX:  BTH ) (FRANKFURT: BTI) (OTCQB:  BTHCF ) (the “ Company ” or “Nash Pharma&#...

Read the whole news https://marketwirenews.com/news-releases/nash-pharmaceuticals-announces-84-reduction-of-fibrosis-by-additional-lead-compound-in-second-pre-clinical-study-for-non-alcoholic-fatty-liver-disease-7324970.html
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent BTI News
More BTI News